No Association of the Complexin-3 Gene Polymorphism with Schizophrenia
Journal: Scientific Journal of Genetics and Gene Therapy (Vol.1, No. 1)Publication Date: 2015-12-30
Authors : Sofi Atshemyan Roksana Zakharyan Arsen Arakelyan;
Page : 027-029
Keywords : Complexin-3; Single nucleotide polymorphism; PCR-SSP; Schizophrenia; Synaptic dysfunctions;
Abstract
Background: Schizophrenia (SCZ) is a multifactorial mental disease. Whereas complex interplay of genes and environment contributes to the SCZ, the disorder has still unclear biological background. Growing amount of evidence showed that synaptic dysfunctions are contributed to SCZ etiopathogenesis.
The context and purpose of the study: Complexin-3, a presynaptic regulatory protein, represents here a special interest. This study was aimed to investigate the potential association of SCZ with rs3743487 single nucleotide polymorphism of the complexin-3 protein encoding gene (CPLX3). A total of 350 unrelated individuals of Armenian nationality (175 SCZ patients and the same number of age-, sex-matched healthy controls) were genotyped for the selected polymorphism using polymerase chain reaction with sequence-specific primers.
Other Latest Articles
- Heredo-Familial and Pediatric GISTs: Spot the Differences
- Optimization of DNA Extraction and PCR Conditions for Genetic Diversity Study in Artemisia Herba- Alba from Algeria
- Identification of Novel TMC1 Compound Heterozygous Mutations Related to Autosomal Recessive Hearing Loss by Targeted Capture Sequencing
- Transcription Factors in Schizophrenia: A Current View of Genetic Aspects
- Role of Molecular Markers in Assessing Genetic Diversity in Mentha: A Review
Last modified: 2019-04-25 21:33:53